Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development
December 19th, 2008
AC Immune SA, a leader in Alzheimer's disease drug development, announced that the World Economic Forum has elected AC Immune as Technology Pioneer 2009 for its accomplishments as an innovation leader and for its breakthrough technologies that can have a deep impact on business and society. Furthermore, AC Immune released that it has reached significant clinical milestones in the development of innovative therapies against Alzheimer's disease. The regulatory authorities have approved the Phase II clinical trial application of the small molecule ACI-91 for the treatment of mild to moderate Alzheimer's disease. Thirdly, AC Immune disclosed that...
Source: Health Business Week (2008-12-19)
|
